Company Profile: Nanosight: Delivering Practical Solutions for Biological Nanotechnology

Abstract

NanomedicineVol. 7, No. 8 News & ViewsCompany Profile: NanoSight: delivering practical solutions for biological nanotechnologyBob Carr & Jeremy WarrenBob CarrNanoSight Limited, Minton Park, London Road, Amesbury, Wiltshire, SP4 7RT, UKSearch for more papers by this author & Jeremy Warren* Author for correspondenceNanoSight Limited, Minton Park, London Road, Amesbury, Wiltshire, SP4 7RT, UK. Search for more papers by this authorEmail the corresponding author at jeremy.warren@nanosight.comPublished Online:30 Aug 2012https://doi.org/10.2217/nnm.12.43AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleReferences1 Gardiner C, Dragovic R, Brooks A, Alvarez L, Harrison P, Sargent I. Visualisation, sizing and counting of cellular microparticles and exosomes using nanoparticle tracking analysis. Presented at: Oxford Biomedical Imaging Festival. Oxford, UK, 16 September 2009.Google Scholar2 Sargent I. Microparticles in pregnancy and pre-eclampsia. Presented at: Micro and Nanovesicles in Health and Disease Conference. Oxford, UK, 23–24 September 2010.Google Scholar3 Malloy A. Count, size and visualize nanoparticles. Mater. Today14(4),170–173 (2011).Crossref, CAS, Google Scholar4 Filipe V, Hawe A, Jiskoot W. Critical evaluation of nanoparticle tracking analysis (NTA) by nanosight for the measurement of nanoparticles and protein aggregates. Pharm. Res.27(5),796–810 (2010).Crossref, Medline, CAS, Google Scholar5 Ghonaim HM, Li S, Blagbrough IS. N1,N12-diacyl spermines: SAR studies on non-viral lipopolyamine vectors for plasmid DNA and siRNA formulation. Pharm. Res.27(1),17–29 (2010).Crossref, Medline, CAS, Google Scholar6 Moser M. Emerging analytical techniques to characterize vaccines. Proc. Intl. Conf. Vaccines Europe. Brussels, December 2008.Google Scholar7 Domingos RF, Peyrot C, Wilkinson KJ. Aggregation of titanium dioxide nano particles: role of calcium and phosphate. Environ. Chem.7,61 (2010).Crossref, CAS, Google Scholar8 Howard AG. On the challenge of quantifying man-made nanoparticles in the aquatic environment. J. Environ. Monit.12,135–142 (2010).Crossref, Medline, CAS, Google Scholar9 Gallego-Urrea JA, Tuoriniemi J, Pallander T, Hassellöv M. Measurements of nanoparticle number concentrations and size distributions in contrasting aquatic environments using nanoparticle tracking analysis. Environ. Chem.7(1),67–81 (2010).Crossref, CAS, Google Scholar10 Farkas J, Christian P, Urrea JA et al. Effects of silver and gold nanoparticles on rainbow trout (Oncorhynchusmykiss) hepatocytes. Aquatic Toxicol.96(1),44–52 (2010).Crossref, Medline, CAS, Google Scholar101 NanoSight directors. www.nanosight.com/about/nanosight-directorsGoogle Scholar102 Official Journal of the European Union. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:275:0038:0040:EN:PDFGoogle ScholarFiguresReferencesRelatedDetailsCited ByCHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity7 April 2022 | Nature Communications, Vol. 13, No. 1Isolation of Extracellular Vesicles from Leishmania spp.28 March 2020Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and MemoryCell, Vol. 177, No. 2Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic BiomarkersMolecular & Cellular Proteomics, Vol. 17, No. 3An In Vitro and In Vivo Comparison of Solid and Liquid–Oil Cores in Transdermal Aconitine NanocarriersJournal of Pharmaceutical Sciences, Vol. 103, No. 11 Vol. 7, No. 8 Follow us on social media for the latest updates Metrics Downloaded 140 times History Published online 30 August 2012 Published in print August 2012 Information© Future Medicine LtdFinancial & competing interests disclosureThe authors are directors, employees and shareholders of NanoSight, while Bob Carr is also the Founder and Chief Technical Officer. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.The article was prepared in conjunction with Jezz Leckenby, Talking Science Limited, NanoSight’s UK-based PR agency.PDF download